Share Price and Basic Stock Data
Last Updated: October 29, 2025, 9:57 pm
| PEG Ratio | 5.28 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
S H Kelkar & Company Ltd (SHK), operating in the Chemicals – Others sector, reported a revenue of ₹1,687 Cr for the fiscal year ending March 2023, reflecting a consistent upward trend from ₹1,564 Cr in FY 2022. This growth trajectory continued, with the latest trailing twelve months (TTM) revenues reaching ₹2,234 Cr. Quarterly sales figures indicate robust performance, with ₹513 Cr recorded in March 2024 and projected increases to ₹567 Cr by March 2025. The company’s ability to generate sales has been supported by operational efficiencies, with a notable operating profit margin (OPM) of 14% in FY 2023. This was an improvement from 13% in the previous year, showcasing effective cost management amidst rising expenses, which stood at ₹1,469 Cr in FY 2023. The revenue growth is indicative of SHK’s strong market presence and operational capabilities, making it a key player in the chemicals landscape.
Profitability and Efficiency Metrics
SHK’s profitability metrics demonstrate a mixed performance. The net profit for FY 2023 was reported at ₹63 Cr, a decline from ₹149 Cr in FY 2022, highlighting challenges in maintaining profitability amidst increasing operational costs. The company’s return on equity (ROE) stood at 7.70%, while the return on capital employed (ROCE) was recorded at 10.3%, both of which are lower compared to industry benchmarks. Operating profit for the trailing twelve months was ₹290 Cr, and the operating profit margin for FY 2025 is anticipated to stabilize around 14%. Efficiency ratios reveal a cash conversion cycle (CCC) of 187 days, reflecting some challenges in inventory and receivables management. Despite these challenges, the interest coverage ratio (ICR) at 6.49x indicates that SHK is well-positioned to meet its interest obligations, showcasing a degree of financial resilience.
Balance Sheet Strength and Financial Ratios
As of March 2025, SHK reported total assets of ₹2,660 Cr, with total borrowings standing at ₹832 Cr, suggesting a manageable debt level given the company’s equity capital of ₹138 Cr. The debt-to-equity ratio was recorded at 0.58, indicating a conservative capital structure relative to the sector’s norms. The company’s reserves have grown to ₹1,134 Cr, up from ₹926 Cr in FY 2023, reflecting a solid retention of earnings and a strategy focused on reinvestment. The price-to-book value ratio (P/BV) was noted at 1.93x, suggesting that the stock is valued relatively higher compared to its book value, which stood at ₹91.89 per share. The current ratio of 1.39x indicates adequate liquidity to cover short-term obligations, while the quick ratio of 0.75x suggests a potential liquidity risk, warranting close monitoring of cash flows to ensure operational continuity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of SHK reflects a stable distribution of ownership, with promoters holding 54.87% as of September 2025, a slight decline from 58.47% in December 2022. This reduction could indicate a shift towards greater public and institutional investor participation, as foreign institutional investors (FIIs) hold 7.36% and domestic institutional investors (DIIs) account for 5.69%. The total number of shareholders increased to 50,971, signaling growing interest in the company. The increase in public shareholding from 26.19% in December 2022 to 32.08% in September 2025 suggests enhanced investor confidence, which is crucial for the company’s market stability. However, the declining promoter stake could raise questions about long-term control and strategic direction, necessitating transparency from management to reassure investors.
Outlook, Risks, and Final Insight
Looking ahead, SHK’s growth will hinge on its ability to navigate rising operational costs while maintaining revenue growth. The company faces risks from fluctuating raw material prices and potential disruptions in global supply chains, which could impact margins. Moreover, the declining net profit trend raises concerns about sustainable profitability. However, strengths such as a solid market position, growing reserves, and a manageable debt profile provide a buffer against these risks. The current interest coverage ratio suggests that SHK can service its debt effectively, which is crucial in a volatile economic environment. If the company can enhance operational efficiencies and stabilize profit margins, it may position itself favorably for future growth. Conversely, failure to address these challenges could hinder its operational and financial stability in the competitive chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of S H Kelkar & Company Ltd (SHK)
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 271 Cr. | 276 | 577/273 | 163 | 165 | 0.36 % | 3.33 % | 1.78 % | 10.0 |
| Deco-Mica Ltd | 32.3 Cr. | 77.0 | 97.0/56.0 | 14.2 | 64.1 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,119 Cr. | 82.6 | 108/64.9 | 20.8 | 117 | 0.97 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 1,056 Cr. | 117 | 121/63.6 | 14.8 | 101 | 1.02 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 89,780 Cr. | 3,028 | 3,325/2,127 | 55.5 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,065.22 Cr | 1,087.81 | 48.78 | 184.86 | 0.37% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 415 | 414 | 385 | 472 | 423 | 455 | 472 | 513 | 470 | 542 | 543 | 567 | 581 |
| Expenses | 360 | 363 | 341 | 405 | 355 | 384 | 396 | 424 | 392 | 462 | 480 | 494 | 508 |
| Operating Profit | 55 | 52 | 43 | 67 | 68 | 72 | 76 | 90 | 78 | 80 | 64 | 73 | 73 |
| OPM % | 13% | 12% | 11% | 14% | 16% | 16% | 16% | 17% | 17% | 15% | 12% | 13% | 13% |
| Other Income | 1 | 9 | 2 | -20 | 2 | 2 | 2 | -0 | -120 | 21 | 1 | 61 | 3 |
| Interest | 5 | 5 | 6 | 7 | 10 | 10 | 10 | 10 | 10 | 13 | 14 | 13 | 13 |
| Depreciation | 20 | 20 | 20 | 21 | 21 | 22 | 22 | 22 | 22 | 24 | 23 | 25 | 26 |
| Profit before tax | 31 | 35 | 19 | 19 | 39 | 41 | 46 | 57 | -74 | 64 | 27 | 97 | 37 |
| Tax % | 26% | 28% | 29% | 94% | 28% | 27% | 30% | 42% | 17% | 38% | 36% | -6% | 30% |
| Net Profit | 23 | 25 | 13 | 1 | 28 | 30 | 32 | 33 | -87 | 40 | 18 | 103 | 26 |
| EPS in Rs | 1.56 | 1.75 | 0.94 | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 |
Last Updated: August 20, 2025, 4:20 am
Below is a detailed analysis of the quarterly data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 581.00 Cr.. The value appears strong and on an upward trend. It has increased from 567.00 Cr. (Mar 2025) to 581.00 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Jun 2025, the value is 508.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 494.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 73.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 58.00 Cr..
- For Interest, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Depreciation, as of Jun 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 60.00 Cr..
- For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from -6.00% (Mar 2025) to 30.00%, marking an increase of 36.00%.
- For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 103.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 77.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.85. The value appears to be declining and may need further review. It has decreased from 7.41 (Mar 2025) to 1.85, marking a decrease of 5.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:10 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,234 |
| Expenses | 628 | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 1,944 |
| Operating Profit | 132 | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 290 |
| OPM % | 17% | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 13% |
| Other Income | 12 | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 86 |
| Interest | 18 | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 53 |
| Depreciation | 19 | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 99 |
| Profit before tax | 109 | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 225 |
| Tax % | 27% | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | |
| Net Profit | 79 | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 185 |
| EPS in Rs | 5,980.35 | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 13.40 |
| Dividend Payout % | 19% | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.39% | 4.29% | 43.84% | -10.48% | -6.38% | -59.09% | 300.00% | 3.47% | -57.72% | 96.83% | -41.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 15.68% | 39.55% | -54.31% | 4.09% | -52.71% | 359.09% | -296.53% | -61.19% | 154.54% | -137.95% |
S H Kelkar & Company Ltd (SHK) has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 21% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: July 25, 2025, 2:27 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 |
| Reserves | 467 | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 |
| Borrowings | 212 | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 |
| Other Liabilities | 169 | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 |
| Total Liabilities | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 |
| Fixed Assets | 251 | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 |
| CWIP | 50 | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 |
| Investments | 0 | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 |
| Other Assets | 559 | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 |
| Total Assets | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 |
Below is a detailed analysis of the balance sheet data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 138.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,134.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,074.00 Cr. (Mar 2024) to 1,134.00 Cr., marking an increase of 60.00 Cr..
- For Borrowings, as of Mar 2025, the value is 832.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 666.00 Cr. (Mar 2024) to 832.00 Cr., marking an increase of 166.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 556.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 502.00 Cr. (Mar 2024) to 556.00 Cr., marking an increase of 54.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,660.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,381.00 Cr. (Mar 2024) to 2,660.00 Cr., marking an increase of 279.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 953.00 Cr.. The value appears strong and on an upward trend. It has increased from 933.00 Cr. (Mar 2024) to 953.00 Cr., marking an increase of 20.00 Cr..
- For CWIP, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 33.00 Cr..
- For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,650.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,425.00 Cr. (Mar 2024) to 1,650.00 Cr., marking an increase of 225.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,660.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,381.00 Cr. (Mar 2024) to 2,660.00 Cr., marking an increase of 279.00 Cr..
Notably, the Reserves (1,134.00 Cr.) exceed the Borrowings (832.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -80.00 | -133.00 | 66.00 | 93.00 | -13.00 | -201.00 | -205.00 | -279.00 | -483.00 | -403.00 | -362.00 | -536.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 |
| Inventory Days | 255 | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 |
| Days Payable | 80 | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 |
| Cash Conversion Cycle | 261 | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 |
| Working Capital Days | 157 | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 |
| ROCE % | 18% | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 1,663,248 | 0.41 | 25.91 | 1,663,248 | 2025-04-22 17:25:21 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Diluted EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Cash EPS (Rs.) | 12.22 | 15.38 | 10.37 | 15.98 | 14.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Revenue From Operations / Share (Rs.) | 153.40 | 139.43 | 121.84 | 113.00 | 93.54 |
| PBDIT / Share (Rs.) | 23.18 | 22.60 | 16.55 | 16.77 | 18.35 |
| PBIT / Share (Rs.) | 16.34 | 16.15 | 10.74 | 11.59 | 14.00 |
| PBT / Share (Rs.) | 8.39 | 13.17 | 7.55 | 9.55 | 13.68 |
| Net Profit / Share (Rs.) | 5.37 | 8.93 | 4.56 | 10.79 | 10.17 |
| NP After MI And SOA / Share (Rs.) | 5.29 | 8.84 | 4.42 | 10.73 | 10.24 |
| PBDIT Margin (%) | 15.11 | 16.21 | 13.58 | 14.84 | 19.61 |
| PBIT Margin (%) | 10.65 | 11.58 | 8.81 | 10.25 | 14.96 |
| PBT Margin (%) | 5.47 | 9.44 | 6.19 | 8.45 | 14.62 |
| Net Profit Margin (%) | 3.50 | 6.40 | 3.74 | 9.55 | 10.87 |
| NP After MI And SOA Margin (%) | 3.44 | 6.34 | 3.62 | 9.49 | 10.94 |
| Return on Networth / Equity (%) | 5.75 | 10.09 | 5.74 | 14.66 | 15.20 |
| Return on Capital Employeed (%) | 14.55 | 15.22 | 9.82 | 10.20 | 14.93 |
| Return On Assets (%) | 2.72 | 5.09 | 2.75 | 6.46 | 7.62 |
| Long Term Debt / Equity (X) | 0.13 | 0.14 | 0.29 | 0.35 | 0.34 |
| Total Debt / Equity (X) | 0.58 | 0.50 | 0.53 | 0.62 | 0.51 |
| Asset Turnover Ratio (%) | 0.83 | 0.83 | 0.74 | 0.55 | 0.60 |
| Current Ratio (X) | 1.39 | 1.46 | 1.70 | 1.70 | 1.82 |
| Quick Ratio (X) | 0.75 | 0.75 | 0.85 | 0.93 | 1.07 |
| Inventory Turnover Ratio (X) | 3.09 | 3.06 | 1.72 | 1.58 | 1.82 |
| Dividend Payout Ratio (NP) (%) | 14.17 | 22.61 | 16.96 | 7.13 | 9.76 |
| Dividend Payout Ratio (CP) (%) | 6.18 | 13.07 | 7.32 | 4.81 | 6.85 |
| Earning Retention Ratio (%) | 85.83 | 77.39 | 83.04 | 92.87 | 90.24 |
| Cash Earning Retention Ratio (%) | 93.82 | 86.93 | 92.68 | 95.19 | 93.15 |
| Interest Coverage Ratio (X) | 6.49 | 7.58 | 9.59 | 14.35 | 15.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.99 | 4.49 | 10.97 | 8.69 |
| Enterprise Value (Cr.) | 3118.96 | 3356.30 | 1912.25 | 2576.78 | 1935.94 |
| EV / Net Operating Revenue (X) | 1.47 | 1.74 | 1.13 | 1.65 | 1.46 |
| EV / EBITDA (X) | 9.72 | 10.73 | 8.35 | 11.10 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| Retention Ratios (%) | 85.82 | 77.38 | 83.03 | 92.86 | 90.23 |
| Price / BV (X) | 1.93 | 2.34 | 1.29 | 1.96 | 1.66 |
| Price / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| EarningsYield | 0.02 | 0.04 | 0.04 | 0.07 | 0.09 |
After reviewing the key financial ratios for S H Kelkar & Company Ltd (SHK), here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 15.38 (Mar 24) to 12.22, marking a decrease of 3.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 153.40. It has increased from 139.43 (Mar 24) to 153.40, marking an increase of 13.97.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.18. This value is within the healthy range. It has increased from 22.60 (Mar 24) to 23.18, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 16.34, marking an increase of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 13.17 (Mar 24) to 8.39, marking a decrease of 4.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.37, marking a decrease of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.29. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 5.29, marking a decrease of 3.55.
- For PBDIT Margin (%), as of Mar 25, the value is 15.11. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 15.11, marking a decrease of 1.10.
- For PBIT Margin (%), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 11.58 (Mar 24) to 10.65, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has decreased from 9.44 (Mar 24) to 5.47, marking a decrease of 3.97.
- For Net Profit Margin (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 6.40 (Mar 24) to 3.50, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 8. It has decreased from 6.34 (Mar 24) to 3.44, marking a decrease of 2.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 15. It has decreased from 10.09 (Mar 24) to 5.75, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 14.55, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 5. It has decreased from 5.09 (Mar 24) to 2.72, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.13, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.58, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. There is no change compared to the previous period (Mar 24) which recorded 0.83.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.75.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 3.06 (Mar 24) to 3.09, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 20. It has decreased from 22.61 (Mar 24) to 14.17, marking a decrease of 8.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 20. It has decreased from 13.07 (Mar 24) to 6.18, marking a decrease of 6.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.83. This value exceeds the healthy maximum of 70. It has increased from 77.39 (Mar 24) to 85.83, marking an increase of 8.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has increased from 86.93 (Mar 24) to 93.82, marking an increase of 6.89.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.58 (Mar 24) to 6.49, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 3.75, marking a decrease of 0.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.96. It has decreased from 3,356.30 (Mar 24) to 3,118.96, marking a decrease of 237.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.47, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.72, marking a decrease of 1.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 85.82. This value exceeds the healthy maximum of 70. It has increased from 77.38 (Mar 24) to 85.82, marking an increase of 8.44.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.93, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in S H Kelkar & Company Ltd (SHK):
- Net Profit Margin: 3.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.55% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.75% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24 (Industry average Stock P/E: 48.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Devkaran Mansion, Mumbai Maharashtra 400002 | investors@keva.co.in https://www.keva.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Vaze | Chairman & Non-Exe.Director |
| Mr. Kedar Vaze | WholeTime Director & Group CEO |
| Mrs. Prabha Vaze | Non Executive Director |
| Mr. Deepak Raj Bindra | Independent Director |
| Mr. Shrikant Oka | Independent Director |
| Mr. Vasant Gujarathi | Independent Director |
| Ms. Neela Bhattacherjee | Independent Director |
FAQ
What is the intrinsic value of S H Kelkar & Company Ltd (SHK)?
S H Kelkar & Company Ltd (SHK)'s intrinsic value (as of 29 October 2025) is 136.46 which is 39.62% lower the current market price of 226.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,132 Cr. market cap, FY2025-2026 high/low of 320/142, reserves of ₹1,134 Cr, and liabilities of 2,660 Cr.
What is the Market Cap of S H Kelkar & Company Ltd (SHK)?
The Market Cap of S H Kelkar & Company Ltd (SHK) is 3,132 Cr..
What is the current Stock Price of S H Kelkar & Company Ltd (SHK) as on 29 October 2025?
The current stock price of S H Kelkar & Company Ltd (SHK) as on 29 October 2025 is 226.
What is the High / Low of S H Kelkar & Company Ltd (SHK) stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of S H Kelkar & Company Ltd (SHK) stocks is 320/142.
What is the Stock P/E of S H Kelkar & Company Ltd (SHK)?
The Stock P/E of S H Kelkar & Company Ltd (SHK) is 24.0.
What is the Book Value of S H Kelkar & Company Ltd (SHK)?
The Book Value of S H Kelkar & Company Ltd (SHK) is 91.9.
What is the Dividend Yield of S H Kelkar & Company Ltd (SHK)?
The Dividend Yield of S H Kelkar & Company Ltd (SHK) is 0.44 %.
What is the ROCE of S H Kelkar & Company Ltd (SHK)?
The ROCE of S H Kelkar & Company Ltd (SHK) is 10.3 %.
What is the ROE of S H Kelkar & Company Ltd (SHK)?
The ROE of S H Kelkar & Company Ltd (SHK) is 7.70 %.
What is the Face Value of S H Kelkar & Company Ltd (SHK)?
The Face Value of S H Kelkar & Company Ltd (SHK) is 10.0.